Search Results - "Barbon, Elena"
-
1
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
Published in Molecular therapy. Methods & clinical development (15-06-2018)“…Pre-existing immunity to adeno-associated virus (AAV) is highly prevalent in humans and can profoundly impact transduction efficiency. Despite the relevance to…”
Get full text
Journal Article -
2
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function
Published in PLoS genetics (26-05-2016)“…Mutations that result in amino acid changes can affect both pre-mRNA splicing and protein function. Understanding the combined effect is essential for correct…”
Get full text
Journal Article -
3
In vivo liver targeted genome editing as therapeutic approach: progresses and challenges
Published in Frontiers in genome editing (2024)“…The liver is an essential organ of the body that performs several vital functions, including the metabolism of biomolecules, foreign substances, and toxins,…”
Get full text
Journal Article -
4
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts
Published in Biochimica et biophysica acta. Gene regulatory mechanisms (01-06-2019)“…Engineered transcription factors (TF) have expanded our ability to modulate gene expression and hold great promise as bio-therapeutics. The first-generation…”
Get full text
Journal Article -
5
Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
Published in EMBO molecular medicine (07-04-2020)“…Novel therapies for hemophilia, including non‐factor replacement and in vivo gene therapy, are showing promising results in the clinic, including for patients…”
Get full text
Journal Article -
6
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
Published in Molecular therapy. Nucleic acids (16-06-2017)“…Exonic duplications account for 10%–15% of all mutations in Duchenne muscular dystrophy (DMD), a severe hereditary neuromuscular disorder. We report a CRISPR…”
Get full text
Journal Article -
7
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
Published in Molecular metabolism (Germany) (01-03-2024)“…Pompe disease (PD) is caused by deficiency of the lysosomal enzyme acid α-glucosidase (GAA), leading to progressive glycogen accumulation and severe myopathy…”
Get full text
Journal Article -
8
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice
Published in Frontiers in genome editing (11-03-2022)“…Many inborn errors of metabolism require life-long treatments and, in severe conditions involving the liver, organ transplantation remains the only curative…”
Get full text
Journal Article -
9
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells
Published in Frontiers in cell and developmental biology (11-05-2023)“…Glycogen storage disease type III (GSDIII) is a rare genetic disease caused by mutations in the gene encoding the glycogen debranching enzyme (GDE). The…”
Get full text
Journal Article -
10
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
Published in Molecular therapy. Nucleic acids (29-11-2016)“…Disease-causing splicing mutations can be rescued by variants of the U1 small nuclear RNA (U1snRNAs). However, the evaluation of the efficacy and safety of…”
Get full text
Journal Article -
11
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Published in Nature Medicine (01-06-2020)Get full text
Magazine Article -
12
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
Published in Gene therapy (01-04-2023)“…Abstract Von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is caused by quantitative or qualitative defects in von…”
Get full text
Journal Article -
13
Regulation of a strong F9 cryptic 5′ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides
Published in Human molecular genetics (01-09-2015)“…Mutations affecting specific splicing regulatory elements offer suitable models to better understand their interplay and to devise therapeutic strategies. Here…”
Get full text
Journal Article -
14
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides
Published in Human molecular genetics (01-09-2015)“…Mutations affecting specific splicing regulatory elements offer suitable models to better understand their interplay and to devise therapeutic strategies. Here…”
Get full text
Journal Article -
15
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
Published in Gene therapy (01-04-2023)“…Von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is caused by quantitative or qualitative defects in von Willebrand factor…”
Get full text
Journal Article -
16
Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model
Published in Human molecular genetics (15-07-2018)“…Abstract Familial dysautonomia (FD) is a rare genetic disease with no treatment, caused by an intronic point mutation (c.2204+6T>C) that negatively affects the…”
Get full text
Journal Article -
17
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes
Published in Scientific reports (24-06-2016)“…Tailored approaches to restore defective transcription responsible for severe diseases have been poorly explored. We tested transcription activator-like…”
Get full text
Journal Article -
18
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Published in Nature Medicine (01-07-2020)“…Neutralizing antibodies to adeno-associated virus (AAV) vectors are highly prevalent in humans 1 , 2 , and block liver transduction 3 – 5 and vector…”
Get full text
Journal Article Magazine Article -
19
Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress
Published in Research and practice in thrombosis and haemostasis (01-07-2022)“…The ISTH London 2022 Congress is the first held (mostly) face‐to‐face again since the COVID‐19 pandemic took the world by surprise in 2020. For 2 years we met…”
Get full text
Journal Article -
20